Would you come back?

Agreed! bad management and egotistical leaders!
I'd rather take my chances somewhere else!

 

AH to be sold

 

Give me a call! I have been out of work for almost a year! I can put up with ANYTHING at this point!

 

For all the haters of ariad.....Call me. I will gladly put up with Q, Hilman, Purdy, and the others...When you get the carpet pulled out from under your feet for no reason, working for them would be a picnic...Just remember that and I truly hope that never happens to you!

 

One of the "desparate" ones!

 

I understand where you are coming from but it's hard to work for a company with egotistical morons at the helm.

 

Pull your teeth and blow me! You are goddamned right I am desperate ! Fuck nuts!

 

Heisenberg

 

No way. Culture blew and drug did too. Good riddance. Got a new gig anyway recently.

 

Will Novartis Oncology suffer now since there are reports of blood clots with Tasigna as well? Interesting how Ariad trials were done with pts who failed with Novartis drugs and blood clots occurred.

 

And you are hanging your hat on this? Get a life! Or are you one of the "desparate" ones?

 

Nope!

Harvey Berger, Ariad Pharmaceuticals

Years ago, Berger was one of the more despised CEOs in bio-pharma. He was viewed as a self-serving bully with an anger problem. At one point in 2008, the independent directors serving on Ariad's board resigned because of Berger. Then Ariad started to develop the leukemia drug ponatinib and the results were impressive. Wall Street investors held their nose and bought Ariad stock, hoping Berger wouldn't screw up a good thing.

For awhile, the strategy worked really well. Ponatinib advanced through clinical trials and was granted FDA approval in December 2012. Ariad's stock price soared, investors were happy. Berger toned down his act and even seemed on a path of redemption.

But no. Call it reversion to the mean, bad luck or both, but Berger's behavior and decision making disintegrated in 2013. The toxicity and side effects associated with ponatinib (now known as Iclusig) became an issue soon after the drug was launched in January. On conference calls, Berger lashed out at critics or seemed defensive. He made excuses for selling Ariad stock. Worst of all (and unknown to investors) Berger was engaged in a fight with the FDA over the agency's growing concerns about blood clots and other heart safety side effects tied to Iclusig. Refusing to cooperate with FDA, particularly when the fight involves serious drug toxicity and the safety of patients is a losing game.

Berger lost. Ariad's patients, employees and shareholders lost too. And once again, Berger is one of the most despised CEO in bio-pharma.

 

Would Pfizer buy Ariad?

 

Not no, but Hail No!

 

Pfizer is still saying WTF from the King deal. If they had money to spend, I'd think they'd have other options.

 

Yeah, sure they would.

 

http://m.youtube.com/watch?v=acLW1vFO-2Q

 

old thread here- but holy cow, that you tube link to George Carlin! I think Trump must have been chnneling him during the campaign!!